An exploratory study of body composition as a predictor of dose-limiting toxicity in metastatic pancreatic cancer treated with gemcitabine plus nab-paclitaxel
Susie Youn, Angela Chen, Vincent Ha, Carole Chambers, Dean T. Eurich, Michael McCall, Michael B. Sawyer
Topics & Concepts
GemcitabineMedicinePancreatic cancerToxicityPaclitaxelBody surface areaInternal medicineOncologyChemotherapyNuclear medicineCancerUrologyGastroenterologyPancreatic and Hepatic Oncology ResearchNutrition and Health in AgingCancer Treatment and Pharmacology